Finasteride Cost in South Carolina 2026

What Does Finasteride Actually Cost in South Carolina Right Now?

Generic finasteride 1 mg costs approximately $12 per month cash-pay at South Carolina retail pharmacies in 2026. Brand-name Propecia carries a manufacturer list price near $85 per month, though almost no one paying out of pocket needs to pay that figure given the wide generic availability.

The price gap between brand and generic exists because finasteride's patent expired years ago, and multiple manufacturers now produce FDA-approved generic tablets. The FDA maintains a searchable database of approved generic drug products, and finasteride 1 mg has numerous approved entries [1]. Choosing generic over brand at a South Carolina pharmacy therefore carries no clinically meaningful difference in efficacy, only a significant difference in cost.

Finasteride 5 mg tablets, used primarily for benign prostatic hyperplasia (BPH), follow a similar pricing pattern. Because the 5 mg tablet can sometimes be split, some men prescribed finasteride 1 mg for androgenetic alopecia (AGA) ask their prescriber about tablet-splitting as a cost-reduction strategy. That conversation belongs with your physician, because pill-splitting has accuracy limitations and is not appropriate for all tablet formulations [2].

Compounded finasteride from a South Carolina-licensed 503A compounding pharmacy costs roughly $45 per month. This option sits between generic retail and brand-name pricing, and it appeals to patients who need a specific dose, formulation, or combination not commercially available [3].

The table below summarizes 2026 South Carolina pricing tiers a patient might encounter:

| Option | Approximate Monthly Cost | Notes | |---|---|---| | Generic finasteride 1 mg (retail) | $12 | Cash-pay; GoodRx/coupons can lower further | | Compounded finasteride (503A) | $45 | Requires licensed SC compounding pharmacy | | Brand Propecia (list price) | $85 | Insurance or manufacturer card may reduce cost |

How Finasteride Works and Why Prescribers Recommend It

Finasteride is a type II 5-alpha reductase inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for follicle miniaturization in genetically susceptible men [4]. Reducing scalp DHT levels slows hair loss progression and, in many patients, stimulates partial regrowth.

The FDA approved finasteride 1 mg (Propecia) for male AGA in 1997 [1]. Kaufman et al. published the key two-year randomized controlled trial in the Journal of the American Academy of Dermatology in 1998 (N=1,553). At 24 months, 83% of men on finasteride 1 mg maintained or increased their hair count versus 28% on placebo. Mean hair count increased by 107 hairs in a 1-inch vertex circle in the finasteride group, compared to a loss of 50 hairs in the placebo group [5]. These figures have anchored prescribing decisions for more than two decades.

The drug's mechanism is well characterized at the molecular level. DHT binds androgen receptors in dermal papilla cells with roughly five times greater affinity than testosterone, driving the transcriptional changes that shorten the anagen growth phase [4]. Finasteride 1 mg reduces scalp DHT by approximately 64% and serum DHT by approximately 68% [6].

The American Academy of Dermatology guidelines list finasteride as a first-line pharmacologic treatment for male AGA [7]. Minoxidil, either topical or oral, is typically the other first-line option. Many clinicians combine both for additive effect, and a 2021 randomized trial published in JAMA Dermatology found that oral minoxidil 5 mg combined with finasteride 1 mg produced greater hair density gains than either drug alone [8].

Sexual side effects, including decreased libido and erectile dysfunction, are reported in roughly 1.3-1.8% of men in clinical trials, rates that were not significantly different from placebo in long-term follow-up data [5]. Patients should discuss their personal risk profile with a licensed prescriber before starting.

Does South Carolina Medicaid Cover Finasteride?

South Carolina Medicaid does not cover finasteride for androgenetic alopecia. The South Carolina Department of Health and Human Services classifies AGA treatment as cosmetic, placing it outside covered benefits [9]. This aligns with most state Medicaid programs nationally, which generally exclude drugs indicated solely for cosmetic purposes under federal Medicaid statute, 42 U.S.C. § 1396r-8(d)(2)(B) [10].

Finasteride 5 mg for BPH occupies a different coverage position because BPH is a medical condition, not a cosmetic one. Coverage for BPH-indication finasteride under SC Medicaid depends on prior authorization criteria and the enrollee's specific managed care plan. Patients prescribed finasteride 5 mg for BPH should contact their SC Medicaid managed care organization directly and request the formulary tier and prior authorization requirements in writing.

Medicare Part D coverage for finasteride also excludes the AGA indication by federal statute. Medicare Part D plans may not cover drugs "when used for cosmetic purposes or hair growth," per 42 C.F.R. § 423.100 [11]. BPH coverage under Part D is formulary-dependent and varies by plan.

Which Private Insurance Plans Cover Finasteride in South Carolina?

Private insurance coverage for finasteride in South Carolina is inconsistent and depends entirely on the individual plan's formulary, the prescribed indication, and whether AGA is specifically carved out as a cosmetic exclusion.

Most employer-sponsored health plans follow the same cosmetic-exclusion logic as Medicaid. A survey of formulary data across major PBMs found that finasteride 1 mg for AGA is excluded from the majority of commercial plans [12]. Finasteride 5 mg for BPH fares better on commercial formularies, typically appearing as a Tier 1 or Tier 2 generic at a $5-$20 copay per month.

Steps to check your specific SC plan:

1. Call the member services number on the back of your insurance card and ask specifically whether "finasteride 1 mg for androgenetic alopecia" is a covered benefit.
2. Request the formulary tier in writing, because verbal coverage estimates from phone representatives are not binding.
3. If denied, ask whether a medical exception or prior authorization pathway exists if a dermatologist documents clinical necessity.

The Affordable Care Act's essential health benefit requirements do not mandate coverage of AGA medications, so insurers retain broad discretion here [13].

Is Compounded Finasteride Legal in South Carolina?

Yes. Compounded finasteride is legal in South Carolina when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. A 503A compounding pharmacy must be state-licensed, comply with USP <795> standards for non-sterile compounding, and fill prescriptions only for individually identified patients [3].

South Carolina's Board of Pharmacy licenses and inspects compounding pharmacies operating within the state. The FDA also maintains oversight authority over 503A pharmacies and issues guidance documents on what substances may be compounded. Finasteride is not on the FDA's list of drug products that have been withdrawn or removed from the market for safety reasons, meaning it is eligible for compounding under 503A [14].

Common reasons a prescriber might order compounded rather than commercially available finasteride include:

• A need for a different dose (for example, 0.5 mg for patients reporting side effects at 1 mg)
• Combination with another active ingredient such as minoxidil in a single formulation
• A patient's documented allergy to an inactive ingredient in a commercial tablet

Patients should verify that any compounding pharmacy they use holds a current South Carolina Board of Pharmacy license. The National Association of Boards of Pharmacy (NABP) Pharmacy Verification program is one independent tool for checking pharmacy credentials [15].

Compounded finasteride costs approximately $45 per month in South Carolina in 2026, roughly 3.75 times more than generic retail but roughly half the brand list price.

Can You Get Finasteride via Telehealth in South Carolina?

Telehealth prescribing of finasteride is fully legal in South Carolina. Under the South Carolina Telehealth Alliance framework and SC Code § 40-47-37, a licensed physician or advanced practice provider may conduct a synchronous or asynchronous telehealth visit and, if clinically appropriate, issue a finasteride prescription to a South Carolina resident [16].

Telehealth platforms that operate in South Carolina must comply with state prescribing standards. The prescriber must establish a valid patient-provider relationship before prescribing, which typically involves a clinical intake questionnaire, photo submission for AGA assessment, and in some platforms a live video visit [16].

Telehealth prescriptions can be routed to any South Carolina retail pharmacy or to a mail-order pharmacy, giving patients significant flexibility. Pricing at retail pharmacies for a telehealth-issued prescription is identical to a prescription issued in a traditional office visit. Generic finasteride 1 mg will still cost approximately $12 per month cash-pay regardless of how the prescription was generated.

The ATA (American Telemedicine Association) has published standards for teledermatology visits that include evaluation of hair loss conditions [17]. Providers using photo-based (asynchronous) assessment for AGA should document photographic evidence of the hair loss pattern consistent with Hamilton-Norwood classification criteria before prescribing [7].

How to Get the Lowest Possible Price on Finasteride in South Carolina

The cheapest route for most South Carolina patients in 2026 is generic finasteride 1 mg at a retail or warehouse pharmacy using a free drug discount card. GoodRx, RxSaver, and similar platforms aggregate pharmacy pricing and negotiate rates. At some SC locations, these cards bring the 30-day supply price of finasteride 1 mg below $10 [18].

Key cost-reduction strategies, ranked by typical savings:

Discount cards at retail pharmacies. Free cards available at GoodRx.com, RxSaver, or NeedyMeds can reduce cash-pay prices at Walgreens, CVS, Walmart, Costco, and Kroger locations across South Carolina. The GoodRx platform reported average prices for finasteride 1 mg in SC in the $8-$12 range for a 30-day supply as of early 2026 [18].

90-day supplies. Filling a 90-day supply instead of 30 days typically reduces per-tablet cost by 15-25% at most pharmacies. SC Medicaid does not cover AGA finasteride, but cash-pay 90-day supplies are available without restriction at retail.

Manufacturer savings programs. Merck's patient assistance program for Propecia is available to qualifying uninsured or underinsured patients. Eligibility is income-based, and applications are processed through the Merck Patient Assistance Program [19]. For most SC patients, however, switching to generic finasteride is simpler and cheaper than navigating a manufacturer assistance application.

Telehealth bundles. Several telehealth platforms offer finasteride as part of a subscription that includes the visit fee and medication cost. These bundled prices range from $20-$35 per month in 2026. Patients should compare whether the bundled price beats generic retail plus a one-time office visit or telehealth consultation fee.

Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at prices below most retail pharmacies. The platform ships to South Carolina and accepts prescriptions from any licensed SC provider [20].

Finasteride Side Effects That Affect Cost Decisions

Understanding the side effect profile matters for cost planning because some patients discontinue finasteride within the first 6-12 months, making upfront investment in a 90-day supply or a compounding contract less economical.

Sexual adverse effects, including decreased libido, ejaculatory disorder, and erectile dysfunction, were reported in 1.3-1.8% of men in the Kaufman et al. trial versus 1.1% in the placebo group [5]. Post-market surveillance has described a subset of men reporting persistent sexual dysfunction after discontinuation, a condition sometimes called post-finasteride syndrome, though the mechanistic evidence base for this entity remains under active investigation [21].

Breast tenderness or gynecomastia occurs in less than 1% of patients [6]. Finasteride lowers PSA (prostate-specific antigen) values by approximately 50%, which clinicians must account for when interpreting PSA screening results in men taking the drug [22].

These considerations do not argue against finasteride for eligible patients. They argue for an informed conversation with a prescriber before starting and for choosing a month-to-month supply rather than a six-month bulk purchase until tolerability is confirmed.

PSA Monitoring and Lab Costs in South Carolina

Because finasteride suppresses PSA by roughly 50%, men over 40 who are already receiving PSA screening should inform their ordering physician that they take finasteride. The FDA label instructs that a doubling of the PSA value should be used to approximate an "untreated" baseline when a patient is on finasteride [1].

PSA testing in South Carolina costs $15-$45 cash-pay at direct-to-consumer lab services such as Quest Diagnostics and LabCorp walk-in locations, or it may be covered under preventive care benefits on most ACA-compliant plans per USPSTF guidance [23]. Adding this monitoring cost into annual finasteride budget calculations is relevant for men over 50 or those with a family history of prostate cancer.

The PCPT (Prostate Cancer Prevention Trial, N=18,882) found that finasteride 5 mg reduced prostate cancer incidence by 24.8% over 7 years compared to placebo, though a higher proportion of high-grade tumors was observed in the finasteride group, a finding subsequently attributed in part to volume-reduction artifact rather than true biological risk increase [24]. This trial used the 5 mg BPH dose, not the 1 mg AGA dose, but the PSA-suppression effect is relevant across both doses.

Comparing Finasteride to Minoxidil: Cost and Clinical Tradeoffs

Topical minoxidil 5% solution costs approximately $10-$15 per month in South Carolina at retail, making it cost-competitive with generic finasteride [25]. Oral minoxidil, prescribed off-label for AGA at doses of 2.5-5 mg, costs roughly $15-$20 per month as a generic.

A 2022 systematic review and meta-analysis in the Journal of the American Academy of Dermatology (N=2,349 across 23 trials) found that finasteride and topical minoxidil produced comparable hair count outcomes at 6 months, with some evidence that finasteride showed greater benefit at 12 months [26]. The clinical takeaway is that both drugs work and many prescribers recommend both together for men with moderate-to-severe AGA.

From a pure cost standpoint in South Carolina in 2026:

• Generic finasteride 1 mg: $12/month
• Topical minoxidil 5%: $10-$15/month
• Oral minoxidil 2.5 mg: $15-$20/month
• Combination (finasteride + topical minoxidil): $22-$27/month cash-pay

The combination remains under $30 per month cash-pay for most SC patients, a meaningful number for patients weighing treatment against the cost of hair restoration procedures, which start near $4,000-$8 to 000 in South Carolina.

What South Carolina Prescribers and Dermatologists Look for Before Prescribing

Board-certified dermatologists and licensed prescribers in South Carolina typically assess the following before initiating finasteride:

Confirmation of androgenetic alopecia pattern using Hamilton-Norwood classification (men) or Ludwig classification (women, though finasteride is not FDA-approved for women) [7]. Ruling out other causes of hair loss such as alopecia areata, telogen effluvium, or scalp disease, which require different treatments entirely [27]. Discussion of reproductive plans, because finasteride is FDA Pregnancy Category X and poses a risk to male fetuses. Women who are or may become pregnant should not handle crushed or broken finasteride tablets [1].

Baseline PSA for men over 40 who are due for prostate cancer screening. The American Urological Association guidelines recommend discussing PSA screening with men starting at age 40 if they are at elevated risk, and at 45-50 for average-risk men [28].

The prescriber should document the Hamilton-Norwood stage, PSA baseline when applicable, and the patient's understanding of the sexual side-effect profile. This documentation standard applies whether the prescription is issued in a traditional clinic or via telehealth.